anti-CBR1 antibody product blog
Tags: Antibody; Monoclonal Antibody; anti-CBR1 antibody; CBR1;
The CBR1 cbr1 (Catalog #MBS9400362) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The CBR1 Monoclonal Antibody reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s CBR1 can be used in a range of immunoassay formats including, but not limited to, Western Blot (WB), Immunocytochemistry (ICC).Western blotting: 1:1000. Researchers should empirically determine the suitability of the CBR1 cbr1 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The CBR1 cbr1 product has the following accession number(s) (GI #557948119) (NCBI Accession #NP_001273718.1) (Uniprot Accession #P16152). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the CBR1 Monoclonal Antibody with the following immunoassay(s):
Immunocytochemistry (ICC) (Immunocytochemistry stain of Hela using CBR1 antibody (1:100).)
Western Blot (WB) (Western blot detection of CBR1 in Hela,A431 & MDA-MB-468 cell lysates using CBR1 antibody(1:1000 diluted).Predicted band size:30KDa,Observed band size:30KDa.)
NADPH-dependent reductase with broad substrate specificity.Catalyzes the reduction of a wide variety of carbonyl compounds including quinones,prostaglandins, menadione,plus various xenobiotics.Catalyzes the reduction of the antitumor anthracyclines doxorubicin and daunorubicin to the cardiotoxic compounds doxorubicinol and daunorubicinol. Can convert prostaglandin E2 to prostaglandin F2-alpha.Can bind glutathione,which explains its higher affinity for glutathione-conjugated substrates.Catalyzes the reduction of S-nitrosoglutathione.
Immunogen Type: Recombinant Protein
Immunogen Description: Purified recombinant human CBR1 protein fragments expressed in E Coli. Target Name: CBR1. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing CBR1 are readily searchable from our website. Different antibodies against the same target such as CBR1 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results. CBR1 also interacts with the following gene(s): AKR1A1, AKR1B1, GCH1, SPR, UBC. Breast Neoplasms, Carcinoma, Hepatocellular, Down Syndrome, Fibrosis, Heart Diseases, Inflammation, Liver Diseases, Liver Neoplasms, Lung Neoplasms, Necrosis are some of the diseases may be linked to CBR1 Monoclonal Antibody. The following patways have been known to be associated with this gene. Blood, Brain, Heart, Liver, Lung, Muscle, Nerve, Ovary, Pancreas, Uterus tissues are correlated with this protein.